WT1 and acute myeloid leukemia: For AML patients after HSCT, lower detection of WT1 mRNA transcripts correlated significantly with a longer survival (p < 0.01) and, conversely, higher detection of WT1 mRNA was associated with relapse and subsequent death of the patients [9].